{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-158353","form_type":"8-K","ticker":"VRCA","cik":"0001660334","company_name":"Verrica Pharmaceuticals Inc.","filed_at":"2024-06-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.474472+00:00","generated_at":"2026-06-01T05:18:56.961605+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Shareholders elect directors and approve advisory proposals at 2024 annual meeting","bullets":["Elected Ted White (13,091,028 for) and Mark Prygocki (12,503,147 for) as directors.","Advisory vote on executive compensation approved: 12,760,245 for, 1,932,076 against.","Advisory vote on frequency of say-on-pay: one year selected with 14,797,140 votes.","Ratification of KPMG LLP as independent auditor approved: 37,151,871 for, 678,830 against.","Approximately 89.2% of outstanding shares were present or represented at the meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-158353","json":"https://secwatch.observer/filing/0001193125-24-158353.json","markdown":"https://secwatch.observer/filing/0001193125-24-158353.md","text":"https://secwatch.observer/filing/0001193125-24-158353.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1660334/000119312524158353/0001193125-24-158353-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1660334/000119312524158353/d834681d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T05:18:56.961605+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}